These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3190187)

  • 1. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.
    Farinotti R; Trouvin JH; Bocquet V; Vermerie N; Carbon C
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1590-2. PubMed ID: 3190187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.
    Nau R; Kinzig M; Dreyhaupt T; Kolenda H; Sörgel F; Prange HW
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1849-53. PubMed ID: 7986019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.
    Guay DR; Opsahl JA; McMahon FG; Vargas R; Matzke GR; Flor S
    Antimicrob Agents Chemother; 1992 Feb; 36(2):308-12. PubMed ID: 1605596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.
    Bethell DB; Day NP; Dung NM; McMullin C; Loan HT; Tam DT; Minh LT; Linh NT; Dung NQ; Vinh H; MacGowan AP; White LO; White NJ
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2167-72. PubMed ID: 8878600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
    Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Movahhed H; Tenney J; Martin RR
    Antimicrob Agents Chemother; 1992 Mar; 36(3):552-7. PubMed ID: 1622165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.
    Goodwin SD; Gallis HA; Chow AT; Wong FA; Flor SC; Bartlett JA
    Antimicrob Agents Chemother; 1994 Apr; 38(4):799-804. PubMed ID: 8031049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
    Guay D; Tack K; Flor S
    Int J Clin Pharmacol Res; 1991; 11(5):203-9. PubMed ID: 1814841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of oral and intravenous ofloxacin after multiple-dose administration to healthy male volunteers.
    Flor SC; Rogge MC; Chow AT
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1468-72. PubMed ID: 8363378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
    Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.
    Yuk JH; Nightingale CH; Quintiliani R; Sweeney KR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):384-6. PubMed ID: 2024973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects.
    Zhang L; Li JT; Lu Y; Li MN; Zhang YL; Liu Y; Li TY; Zhang JW
    Acta Pharmacol Sin; 2002 Apr; 23(4):381-4. PubMed ID: 11931699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Hernández RM; Calvo B; Errasti J; Pedraz Muñoz JL
    J Clin Pharmacol; 2000 Aug; 40(8):869-74. PubMed ID: 10934671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Passlick J; Wonner R; Keller E; Essers L; Grabensee B
    Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Ambros LA; Landoni MF
    J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.